Tuvusertib (M1774)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tuvusertib (M1774), covering 2026-02-19 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320) [Phase 1]